ArrayExpress Uploader0mouse0 mg/kgVehicleWildtype0 mg/kgVehicleWildtype0 mg/kgVehicleWildtype150 mg/kgGW4064Wildtype150 mg/kgGW4064Wildtype150 mg/kgGW4064Wildtype0 mg/kgVehicleLiver Fxr KO0 mg/kgVehicleLiver Fxr KO0 mg/kgVehicleLiver Fxr KO150 mg/kgGW4064Liver Fxr KO150 mg/kgGW4064Liver Fxr KO150 mg/kgGW4064Liver Fxr KO0 mg/kgVehicleWhole body Fxr KO0 mg/kgVehicleWhole body Fxr KO0 mg/kgVehicleWhole body Fxr KO150 mg/kgGW4064Whole body Fxr KO150 mg/kgGW4064Whole body Fxr KO150 mg/kgGW4064Whole body Fxr KO8747arrayexpress_sid8Expression profiling of whole body (WB) FXR knockout (KO) mice (FXR WB KO), liver-specific FXR KO mice (AFXR Cre+) and enterocyte...E-GEOD-54557/profile/8773/arrayexpressuploader318bodyenterocyteliverDec.12, 2014FalseE-GEOD-54557_A-AFFY-36transcription-profiling-of-liver-from-farnesoid-xTranscription profiling of liver from farnesoid X receptor knockout miceNov.24, 2014Expression profiling of whole body (WB) FXR knockout (KO) mice (FXR WB KO), liver-specific FXR KO mice (AFXR Cre+) and enterocyte specific FXR KO mice (VFXR Cre+) on a C57BL/6J genetic background Whole body (WB) FXR knockout (KO) mice (FXR WB KO), liver-specific FXR KO mice (AFXR Cre+) and enterocyte specific FXR KO mice (VFXR Cre+) on a C57BL/6J genetic background were bred and maintained in the laboratory animal research facility at the University of Kansas Medical Center in rooms under a 12-hour light-dark cycle. All experiments used 10-16 week-old male mice. FXR was activated by treatment with the FXR synthetic agonist, GW4064, at 150 mg/kg. GW4064 or vehicle was administered by oral gavage at 6 p.m., followed by a second administration at 8 a.m. the next morning. Two hours later, the liver was harvested.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-54557http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-54557/samples/